This department is offering a grant to support pilot testing of innovative interventions for mental disorders in adults and children. The aim is to accelerate the translation of emerging basic science findings into practical treatments that improve functionality and reduce symptoms in individuals with mental disorders. Grants will fund milestone-driven testing and validation of therapeutic targets in the R21 phase, followed by additional support for studies linking changes in intervention targets to functional or clinical effects in the R33 phase. Researchers are encouraged to explore a range of interventions, including behavioral, pharmacological, and device-based approaches. Application deadline: April 23, 2015.
Opportunity ID: 275507
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-MH-16-405 |
Funding Opportunity Title: | Exploratory Clinical Trials of Novel Interventions for Mental Disorders (R21/R33) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.242 — Mental Health Research Grants |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Mar 30, 2015 |
Last Updated Date: | Apr 23, 2015 |
Original Closing Date for Applications: | Oct 14, 2016 |
Current Closing Date for Applications: | Apr 23, 2015 |
Archive Date: | May 23, 2015 |
Estimated Total Program Funding: | $4,000,000 |
Award Ceiling: | $200,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | For profit organizations other than small businesses City or township governments Private institutions of higher education Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education State governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Special district governments County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support the efficient pilot testing of novel interventions for mental disorders in adults and children through an experimental therapeutics approach. Under this FOA, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support go/no-go decisions about further development or testing of the intervention. Studies of novel interventions include, but are not limited to behavioral, pharmacological, biologics-based, cognitive, device-based, interpersonal, physiological, or combined approaches. Support will be provided for up to two years (R21 phase) for preliminary milestone-driven testing and validating of the interventions therapeutic target, possibly followed by up to 3 years of support (R33 phase) for studies relating change in the intervention target to functional or clinical effects. Ultimately, this R21/R33 FOA is intended to speed the translation of emerging basic science findings of mechanisms and processes underlying mental disorders into novel interventions that can be efficiently tested for their promise in restoring function and reducing symptoms for those living with mental disorders. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-16-405.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Modified the close date field, in accordance with NOT-MH-15-018. | Apr 23, 2015 | |
Apr 23, 2015 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-MH-16-405 |
Funding Opportunity Title: | Exploratory Clinical Trials of Novel Interventions for Mental Disorders (R21/R33) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.242 — Mental Health Research Grants |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Mar 30, 2015 |
Last Updated Date: | Apr 23, 2015 |
Original Closing Date for Applications: | Oct 14, 2016 |
Current Closing Date for Applications: | Apr 23, 2015 |
Archive Date: | May 23, 2015 |
Estimated Total Program Funding: | $4,000,000 |
Award Ceiling: | $200,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | For profit organizations other than small businesses City or township governments Private institutions of higher education Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education State governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Special district governments County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support the efficient pilot testing of novel interventions for mental disorders in adults and children through an experimental therapeutics approach. Under this FOA, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support go/no-go decisions about further development or testing of the intervention. Studies of novel interventions include, but are not limited to behavioral, pharmacological, biologics-based, cognitive, device-based, interpersonal, physiological, or combined approaches. Support will be provided for up to two years (R21 phase) for preliminary milestone-driven testing and validating of the interventions therapeutic target, possibly followed by up to 3 years of support (R33 phase) for studies relating change in the intervention target to functional or clinical effects. Ultimately, this R21/R33 FOA is intended to speed the translation of emerging basic science findings of mechanisms and processes underlying mental disorders into novel interventions that can be efficiently tested for their promise in restoring function and reducing symptoms for those living with mental disorders. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-16-405.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-MH-16-405 |
Funding Opportunity Title: | Exploratory Clinical Trials of Novel Interventions for Mental Disorders (R21/R33) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.242 — Mental Health Research Grants |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 23, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Oct 14, 2016 |
Archive Date: | Nov 14, 2016 |
Estimated Total Program Funding: | $4,000,000 |
Award Ceiling: | $200,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Special district governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) State governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses County governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education City or township governments Small businesses Private institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support the efficient pilot testing of novel interventions for mental disorders in adults and children through an experimental therapeutics approach. Under this FOA, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support go/no-go decisions about further development or testing of the intervention. Studies of novel interventions include, but are not limited to behavioral, pharmacological, biologics-based, cognitive, device-based, interpersonal, physiological, or combined approaches. Support will be provided for up to two years (R21 phase) for preliminary milestone-driven testing and validating of the interventions therapeutic target, possibly followed by up to 3 years of support (R33 phase) for studies relating change in the intervention target to functional or clinical effects. Ultimately, this R21/R33 FOA is intended to speed the translation of emerging basic science findings of mechanisms and processes underlying mental disorders into novel interventions that can be efficiently tested for their promise in restoring function and reducing symptoms for those living with mental disorders. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-16-405.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-C | FORMS-C | PKG00215867 | Apr 23, 2015 | Apr 24, 2015 | View |
Package 1
Mandatory forms
275507 RR_SF424_2_0-2.0.pdf
275507 PHS398_ResearchPlan_2_0-2.0.pdf
275507 PHS398_CoverPageSupplement_2_0-2.0.pdf
275507 RR_Budget_1_3-1.3.pdf
275507 RR_KeyPersonExpanded_2_0-2.0.pdf
275507 RR_OtherProjectInfo_1_3-1.3.pdf
275507 PerformanceSite_2_0-2.0.pdf
Optional forms
275507 PlannedReport-1.0.pdf
275507 PHS398_CumulativeInclusionReport-1.0.pdf
275507 RR_SubawardBudget30_1_3-1.3.pdf